ASX - By Stock
|
WBT |
Re:
Ann: Weebit Nano Investor Presentation
|
|
mervco54
|
175 |
58K |
0 |
24/03/24 |
24/03/24 |
ASX - By Stock
|
175
|
58K
|
0
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit Nano Investor Presentation
|
|
mervco54
|
175 |
58K |
1 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
175
|
58K
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit Nano Investor Presentation
|
|
mervco54
|
175 |
58K |
6 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
175
|
58K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
mervco54
|
12K |
6.0M |
3 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
12K
|
6.0M
|
3
|
|
ASX - By Stock
|
PRX Mining |
Re:
Upcoming Dividend???
|
|
mervco54
|
23 |
5.8K |
0 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
23
|
5.8K
|
0
|
|
ASX - By Stock
|
CLZ |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
mervco54
|
92 |
23K |
1 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
92
|
23K
|
1
|
|
Charts
|
DRE |
Re:
DRE Chart
|
|
mervco54
|
3.4K |
1.5M |
1 |
24/01/24 |
24/01/24 |
Charts
|
3.4K
|
1.5M
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Notification regarding unquoted securities - WBT
|
|
mervco54
|
14 |
5.1K |
4 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
14
|
5.1K
|
4
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Notification of cessation of securities - GTG
|
|
mervco54
|
1 |
611 |
5 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
1
|
611
|
5
|
|
ASX - By Stock
|
GTG |
Re:
GTG/GENE Stock Performance
|
|
mervco54
|
16 |
4.0K |
1 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
16
|
4.0K
|
1
|
|
ASX - By Stock
|
GTG |
Re:
GTG/GENE Stock Performance
|
|
mervco54
|
16 |
4.0K |
0 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
16
|
4.0K
|
0
|
|
ASX - By Stock
|
WWI |
Re:
Ann: Application for quotation of securities - WWI
|
|
mervco54
|
5 |
1.0K |
3 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
5
|
1.0K
|
3
|
|
ASX - By Stock
|
WWI |
Re:
Ann: Application for quotation of securities - WWI
|
|
mervco54
|
5 |
1.0K |
2 |
08/11/23 |
08/11/23 |
ASX - By Stock
|
5
|
1.0K
|
2
|
|
ASX - By Stock
|
LPD |
Re:
Lepidico secures N$950m for Namibian lithium project
|
|
mervco54
|
46 |
17K |
6 |
28/10/23 |
28/10/23 |
ASX - By Stock
|
46
|
17K
|
6
|
|
ASX - By Stock
|
ANL |
Re:
Ann: Annual Report to shareholders
|
|
mervco54
|
3 |
2.5K |
0 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
3
|
2.5K
|
0
|
|
ASX - By Stock
|
MTH |
Re:
Ann: Scheme Booklet registered by ASIC
|
|
mervco54
|
15 |
8.8K |
0 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
15
|
8.8K
|
0
|
|
ASX - By Stock
|
MTH |
Re:
Ann: Scheme Booklet registered by ASIC
|
|
mervco54
|
15 |
8.8K |
4 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
15
|
8.8K
|
4
|
|
ASX - Day Trading
|
|
Re:
Day trading pre-market open September 6
|
|
mervco54
|
48 |
10K |
4 |
06/09/23 |
06/09/23 |
ASX - Day Trading
|
48
|
10K
|
4
|
|
ASX - By Stock
|
CLZ |
Re:
Ann: Classic pours First Gold Bar - Clarifying announcement
|
|
mervco54
|
36 |
9.5K |
1 |
20/08/23 |
20/08/23 |
ASX - By Stock
|
36
|
9.5K
|
1
|
|
ASX - By Stock
|
ANL |
Re:
Ann: Results of Meeting
|
|
mervco54
|
10 |
3.2K |
1 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
10
|
3.2K
|
1
|
|
ASX - By Stock
|
CLZ |
Re:
Ann: Trading Halt
|
|
mervco54
|
58 |
20K |
17 |
19/06/23 |
19/06/23 |
ASX - By Stock
|
58
|
20K
|
17
|
|
ASX - By Stock
|
MNB |
Re:
TA/chart
|
|
mervco54
|
343 |
90K |
2 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
343
|
90K
|
2
|
|
ASX - By Stock
|
CLZ |
Re:
Ann: Results of Meeting
|
|
mervco54
|
1 |
776 |
1 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
1
|
776
|
1
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
mervco54
|
30K |
15M |
2 |
14/05/23 |
14/05/23 |
Charts
|
30K
|
15M
|
2
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
mervco54
|
30K |
15M |
4 |
14/05/23 |
14/05/23 |
Charts
|
30K
|
15M
|
4
|
|
ASX - By Stock
|
RLG |
Re:
Ann: Change of Director's Interest Notice
|
|
mervco54
|
4 |
1.0K |
1 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
4
|
1.0K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
Ann: FSGS Study, Partnering & Commercialisation Investor Briefing
|
|
mervco54
|
111 |
45K |
4 |
23/03/23 |
23/03/23 |
ASX - By Stock
|
111
|
45K
|
4
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit Nano retail investor briefings
|
|
mervco54
|
255 |
111K |
1 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
255
|
111K
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit Nano retail investor briefings
|
|
mervco54
|
255 |
111K |
5 |
13/03/23 |
13/03/23 |
ASX - By Stock
|
255
|
111K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
mervco54
|
12K |
6.0M |
6 |
07/03/23 |
07/03/23 |
ASX - By Stock
|
12K
|
6.0M
|
6
|
|
ASX - By Stock
|
GTG |
Re:
Ann: 2023 Half-year Financial Results Investor Webinar
|
|
mervco54
|
6 |
2.2K |
0 |
25/02/23 |
25/02/23 |
ASX - By Stock
|
6
|
2.2K
|
0
|
|
ASX - By Stock
|
GTG |
Re:
Ann: 2023 Half-year Financial Results Investor Webinar
|
|
mervco54
|
6 |
2.2K |
1 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
6
|
2.2K
|
1
|
|
ASX - By Stock
|
WBT |
Re:
Running discussion on SP
|
|
mervco54
|
7.2K |
2.9M |
9 |
20/02/23 |
20/02/23 |
ASX - By Stock
|
7.2K
|
2.9M
|
9
|
|
ASX - By Stock
|
RLG |
Re:
Ann: RLG Issues Shares on achievement of Milestones
|
|
mervco54
|
8 |
2.5K |
8 |
11/02/23 |
11/02/23 |
ASX - By Stock
|
8
|
2.5K
|
8
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
mervco54
|
30K |
15M |
4 |
02/02/23 |
02/02/23 |
Charts
|
30K
|
15M
|
4
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Appendix 4C and Quarterly Business Update December 2022
|
|
mervco54
|
10 |
2.4K |
0 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
10
|
2.4K
|
0
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Appendix 4C and Quarterly Business Update December 2022
|
|
mervco54
|
10 |
2.4K |
0 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
10
|
2.4K
|
0
|
|
ASX - By Stock
|
GTG |
Re:
Ann: Appendix 4C and Quarterly Business Update December 2022
|
|
mervco54
|
10 |
2.4K |
0 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
10
|
2.4K
|
0
|
|
ASX - By Stock
|
PAM |
Re:
Ann: Request for an extension of the suspension
|
|
mervco54
|
29 |
7.4K |
2 |
20/12/22 |
20/12/22 |
ASX - By Stock
|
29
|
7.4K
|
2
|
|
ASX - By Stock
|
RMX |
Re:
Ann: RMX Acquires Strategic Lithium Projects in Nevada USA
|
|
mervco54
|
16 |
7.6K |
4 |
07/12/22 |
07/12/22 |
ASX - By Stock
|
16
|
7.6K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: First Patient Dosed in VAXINIA Intravenous Cohort 2
|
|
mervco54
|
30 |
17K |
1 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
30
|
17K
|
1
|
|
ASX - By Stock
|
ANL |
Re:
Ann: Results of Meeting
|
|
mervco54
|
3 |
1.7K |
2 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
3
|
1.7K
|
2
|
|
ASX - By Stock
|
RLG |
Re:
Ann: Results of Meeting
|
|
mervco54
|
4 |
1.9K |
2 |
29/11/22 |
29/11/22 |
ASX - By Stock
|
4
|
1.9K
|
2
|
|
ASX - By Stock
|
EX1 |
Re:
Ann: Results of Meeting
|
|
mervco54
|
3 |
1.8K |
2 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
3
|
1.8K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Investor Presentation
|
|
mervco54
|
17 |
12K |
1 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
17
|
12K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Investor Presentation
|
|
mervco54
|
17 |
12K |
3 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
17
|
12K
|
3
|
|
ASX - By Stock
|
CLZ |
Re:
Ann: Results of Meeting
|
|
mervco54
|
4 |
1.2K |
0 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
4
|
1.2K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Prospectus for the issue of institutional placement options
|
|
mervco54
|
69 |
26K |
4 |
17/09/22 |
17/09/22 |
ASX - By Stock
|
69
|
26K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Prospectus for the issue of institutional placement options
|
|
mervco54
|
69 |
26K |
4 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
69
|
26K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Prospectus for the issue of institutional placement options
|
|
mervco54
|
69 |
26K |
1 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
69
|
26K
|
1
|
|